Daiwa Securities Group Inc. Evolus, Inc. Transaction History
Daiwa Securities Group Inc.
- $27.1 Billion
- Q2 2025
A detailed history of Daiwa Securities Group Inc. transactions in Evolus, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 262 shares of EOLS stock, worth $1,608. This represents 0.0% of its overall portfolio holdings.
Number of Shares
262
Previous 262
-0.0%
Holding current value
$1,608
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EOLS
# of Institutions
186Shares Held
55.3MCall Options Held
1.21MPut Options Held
48.5K-
Tang Capital Management LLC San Diego, CA5MShares$30.7 Million2.76% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.2MShares$25.8 Million1.69% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$24.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.32MShares$20.4 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.47MShares$15.2 Million1.0% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $344M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...